← Back to Search
Design Of Lipid Nanoparticles For The Oral Delivery Of Hydrophilic Macromolecules
M. Garcia-Fuentes, Dolores Torres, M. Alonso
Published 2003 · Chemistry
Download PDFAnalyze on Scholarcy
Abstract Colloidal drug carriers prepared from solid triglycerides have been presented as a promising alternative to polymer nanoparticles. The present work is aimed at developing surface-modified lipid nanoparticles intended to encapsulate peptides within their structure and to study their physicochemical properties and in vitro stability in gastrointestinal fluids. The final goal is to explore their potential as oral delivery vehicles for macromolecules. The W/O/W multiple emulsion technique was originally applied and conveniently modified for the production of tripalmitin nanoparticles. This technique was selected because its makes the encapsulation of peptides feasible. Additionally, the surface of the particles could be modified through the incorporation of Poloxamer 188 or the lipid derivative PEG 2000-stearate into the formulation. This modification led to a reduction in the zeta potential values, varying from −34 mV for the non-coated particles to −20 mV for those prepared with PEG-stearate. Results of the stability of the nanoparticles in gastric and intestinal media indicate that the low pH of the gastric medium and the pancreatic enzymes in intestinal medium are responsible for the extensive aggregation and degradation of the non-coated lipid nanoparticles (80% degradation in 4 h). In contrast, PEG-stearate coated nanoparticles were more stable, as their polymer coating layer totally prevented aggregation in both media and significantly reduced pancreatin-induced degradation (40% approximately in 4 h). Preliminary studies showed that insulin, chosen as a model peptide, could be associated and released from PEG-stearate coated nanoparticles. Nevertheless, further work is required in order to optimize the release behavior of the entrapped peptide.
This paper references
Microparticulate systems for the delivery of proteins and vaccines
S. Cohen (1996)
Gastrointestinal Uptake of Biodegradable Microparticles: Effect of Particle Size
M. P. Desai (2004)
Enzymatic degradation of SLN-effect of surfactant and surfactant mixtures.
C. Olbrich (1999)
The Oral Absorption of Micro- and Nanoparticulates: Neither Exceptional Nor Unusual
A. Florence (2004)
Calcitonin and Insulin in Isobutylcyanoacrylate Nanocapsules: Protection Against Proteases and Effect on Intestinal Absorption in Rats
P. J. Lowe (1994)
Preparation of submicron drug particles in lecithin-stabilized o/w emulsions. II. Characterization of cholesteryl acetate particles
B. Sjoestroem (1993)
Physicochemical characterization of lipid nanoparticles and evaluation of their drug loading capacity and sustained release potential
K. Westesen (1997)
Evidence for Phospholipid Bilayer Formation in Solid Lipid Nanoparticles Formulated with Phospholipid and Triglyceride
H. Heiati (2004)
Oral particulate delivery: status and future trends.
THE INTESTINAL UPTAKE OF PARTICLES AND THE IMPLICATIONS FOR DRUG AND ANTIGEN DELIVERY
O'Hagan Dt (1996)
Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art.
R. Mueller (2000)
Principles of colloid and surface chemistry
P. C. Hiemenz (1977)
Investigations on solid lipid nanoparticles prepared by precipitation in o/w emulsions
B. Siekmann (1996)
'Stealth' corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption.
Peptide-loaded solid lipid nanoparticles (SLN): Influence of production parameters
A. J. Almeida (1997)
A new nanocapsule formulation with hydrophilic core : Application to the oral administration of salmon calcitonin in rats
H. Vranckx (1996)
Modification of Intestinal Absorption of Drugs by Lipoidal Adjuvants
S. Muranishi (2004)
Nanoparticles as carriers for oral peptide absorption: Studies on particle uptake and fate
A. T. Florence (1995)
Nanoparticle Uptake by the Rat Gastrointestinal Mucosa: Quantitation and Particle Size Dependency
P. Jani (1990)
Biodegradation of solid lipid nanoparticles as a function of lipase incubation time
R. Mueller (1996)
Protein—surface interactions in the presence of polyethylene oxide: I. Simplified theory
S. Jeon (1991)
Electrolyte- and pH-stabilities of aqueous solid lipid nanoparticle (SLN) dispersions in artificial gastrointestinal media.
E. Zimmermann (2001)
Optimization of procedure parameters and physical stability of solid lipid nanoparticles in dispersions
P. Ahlin (1998)
Influence of coating agents on the degradation of poly(D,L-lactic acid) nanoparticles in model digestive fluids (USP XXII)
F. J. Landry (1996)
Cytotoxicity of magnetite-loaded polylactide, polylactide/glycolide particles and solid lipid nanoparticles
R. Mueller (1996)
Solid lipid nanoparticles (SLN) for controlled drug delivery--drug release and release mechanism.
A. Zur Mühlen (1998)
New Approach for Oral Administration of Insulin With Polyalkylcyanoacrylate Nanocapsules as Drug Carrier
C. Damgé (1988)
Nanocapsules as carriers for oral peptide delivery
C. Damgé (1990)
The role of PEG on the stability in digestive fluids and in vivo fate of PEG-PLA nanoparticles following oral administration.
Fate of 14C radiolabeled poly(DL-lactic acid) nanoparticles following oral administration to rats
C. Ropert (1993)
Stability determination of solid lipid nanoparticles (SLN) in aqueous dispersion after addition of electrolyte.
C. Freitas (1999)
Degradation of poly(D,L-lactic acid) nanoparticles coated with albumin in model digestive fluids (USP XXII).
F. Landry (1996)
Biologically erodable microspheres as potential oral drug delivery systems
E. Mathiowitz (1997)
Investigation of the gel formation of phospholipid-stabilized solid lipid nanoparticles
K. Westesen (1997)
This paper is referenced by
Hydrophilic Microspheres from Water-in-Oil Emulsions by the Water Diffusion Technique
M. Trotta (2004)
Nanotechnology in Pharmaceutical Manufacturing
Yiguang Jin (2010)
Biomimetic aqueous-core lipid nanoballoons integrating a multiple emulsion formulation: a suitable housing system for viable lytic bacteriophages.
Victor M Balcão (2014)
Targeted Delivery of Protein Drugs by Nanocarriers
R. Solaro (2010)
Nanostructured lipid carriers of olmesartan medoxomil with enhanced oral bioavailability.
Vikram Kaithwas (2017)
Biopharmaceutical characterisation of insulin and recombinant human growth hormone loaded lipid submicron particles produced by supercritical gas micro-atomisation.
S. Salmaso (2009)
Preparation and Characterization
J. Wu (2018)
Development and Optimization of Biocompatible, Biodegradable Solid Lipid Nanoparticles Containing
Curcumin Hamdy (2014)
Controlling properties of micro‐ to nano‐sized dispersions using emulsification devices
Zheng Wang (2015)
Influence of polymer molecular weight on the solid-state structure of PEG/Monoolein mixtures
D. Mahlin (2005)
PEG-stearate coated solid lipid nanoparticles as levothyroxine carriers for oral administration
Soheila Kashanian (2014)
Special Focus Report Introduction
Yanhang Zhang ()
Parenteral Delivery of Peptides and Proteins
H. Agrawal (2011)
Lipid-based nanocarriers for oral peptide delivery.
Zhigao Niu (2016)
Solid lipid nanoparticles coated with cross-linked polymeric double layer for oral delivery of curcumin.
Taoran Wang (2016)
Optimization of lyophilization parameters of polymeric nanoparticles for delivery of therapeutic proteins
P. Fonte (2016)
Nanoparticulate Drug Delivery Systems
Jaya Raja Kumar Kalaimani (2016)
Lipophilic peptide character - What oral barriers fear the most.
O. Zupančič (2017)
SOLID LIPID NANOPARTICLES: THE EFFICIENCY CARRIER FOR TOPICAL DELIVERY OF HYDROPHILIC DRUGS
Laysa Nobre Almeida (2017)
Novel method to label solid lipid nanoparticles with 64cu for positron emission tomography imaging.
Erica M Andreozzi (2011)
Preparation of solid lipid nanoparticles as drug carriers for levothyroxine sodium with in vitro drug delivery kinetic characterization
E. Rostami (2014)
Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products.
J. Pardeike (2009)
Nanocarreadores lipídicos contendo quercetina: desenvolvimento, caracterização físico-química e avaliação biológica in vivo
C. Dora (2012)
Nanocápsulas policatiónicas: nuevos sistemas para la liberación intracelular de fármacos antitumorales
María Victoria Lozano López (2011)
Stabilization of Water Droplets in an Oily Matrix Exclusively by Gel Formation
F. Wolf (2012)
Inhalable Microparticles as Carriers for Pulmonary Delivery of Thymopentin-Loaded Solid Lipid Nanoparticles
Y. Li (2010)
Interactions of the antimicrobial peptide nisin Z with conventional antibiotics and the use of nanostructured lipid carriers to enhance antimicrobial activity.
Angélique Lewies (2017)
Lipid-based nanocarriers for the oral administration of biopharmaceutics.
T. Karamanidou (2016)
A comparative study of the potential of solid triglyceride nanostructures coated with chitosan or poly(ethylene glycol) as carriers for oral calcitonin delivery.
M. Garcia-Fuentes (2005)
Surface Modification of Nanoparticles for Targeted Drug Delivery
Y. Pathak (2019)
Formulation and application of a new generation of lipid nano-carriers for the food bioactive ingredients
Iman Katouzian (2017)
Characterization of particulate drug delivery systems for oral delivery of Peptide and protein drugs.
Philip Carsten Christophersen (2015)See more